Trials / Completed
CompletedNCT03759197
A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis
A Double-Blind, Randomized, Multicenter, Vehicle-Controlled, Parallel Group Comparison Study to Determine the Efficacy and Safety of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis Receiving Up to Four Weeks of Twice-Daily Treatment (Study 305)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 206 (actual)
- Sponsor
- Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This Phase 3 study (Study 305) has been designed to determine and compare the efficacy and safety of 188-0551 Spray and Vehicle Spray applied twice daily for up to four weeks in subjects with plaque psoriasis. Subjects will be instructed to apply the test article (188-0551 Spray or Vehicle Spray) to all psoriasis plaques within the designated Treatment Area twice daily for four weeks (Study Day 29), unless the investigator verifies the subject's psoriasis has cleared at Day 15, then test article application will be for 2 weeks (Study Day 15).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 188-0551 Spray | Topical Spray containing active drug |
| DRUG | Vehicle Spray | Topical Spray containing no active drug |
Timeline
- Start date
- 2018-11-26
- Primary completion
- 2019-08-27
- Completion
- 2019-08-27
- First posted
- 2018-11-29
- Last updated
- 2020-02-25
Locations
12 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03759197. Inclusion in this directory is not an endorsement.